Multiple Myeloma clinical trials
- Phase
- Phase 3
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 2
- Phase
- Phase 1
- Phase
- Phase 1
- Phase
- Phase 2
- Phase
- Phase 2
- Phase
- Phase 3
- Phase
- Phase 1
- Phase
- Phase 1/2
- Phase
- Phase 3
Access comprehensive clinical trial information for Multiple Myeloma through Pure Global AI's free database. This collection includes 1,574 clinical trials across multiple phases including Phase 2, N/A, Phase 1. Currently, 328 trials are actively recruiting participants.
Research for Multiple Myeloma is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include Celgene and University of Arkansas. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 1,574 clinical trials studying Multiple Myeloma, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Celgene, University of Arkansas, Janssen Research & Development, LLC, among others.